Gheuens Sarah

CIK 00018811902 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001881190

Recent Transactions

50 trades

Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-07-01$37.56/sh−4,007→ 84,645 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-07-01+8,375→ 88,652 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-07-01−8,375→ 0 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2026-07-01+32,341→ 32,341 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2026-06-18−3,000→ 9,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-06-18+3,000→ 3,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-04-02+8,500→ 83,217 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-04-02$34.71/sh−2,940→ 80,277 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2026-04-02−8,500→ 8,500 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-02−5,666→ 5,667 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02+4,000→ 75,593 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02+5,666→ 73,274 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02+4,000→ 68,795 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-02−4,000→ 8,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02$28.96/sh−1,187→ 74,406 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-02−4,000→ 0 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02$28.96/sh−1,187→ 67,608 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2026-03-02$28.96/sh−1,681→ 71,593 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-01+14,000→ 14,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2026-03-01+52,000→ 52,000 total
Award
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2026-03-01+22,000→ 22,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30+6,000→ 67,727 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-12-30$27.09/sh−2,932→ 64,795 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-12-30−6,000→ 0 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-11-11−2,454→ 26,130 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-11-11$43.78/sh−2,454→ 61,727 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-11-11$25.01/sh+2,454→ 64,181 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-10-30$25.01/sh+200→ 61,927 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-10-30$43.81/sh−200→ 61,727 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-10-30−200→ 28,584 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-10-27−3,302→ 28,784 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-10-27$43.92/sh−3,302→ 61,727 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-10-27$25.01/sh+3,302→ 65,029 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-09$38.76/sh−847→ 61,271 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-09$37.93/sh−11,067→ 62,118 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Stock options (right to buy)
2025-07-09−11,914→ 32,086 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-09$25.01/sh+11,914→ 73,185 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-01+8,374→ 65,362 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-07-01$34.17/sh−4,091→ 61,271 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-07-01−8,374→ 8,375 total
Award
Viridian Therapeutics, Inc.\DE$VRDN
Stock Option (Right to Buy)
2025-07-01+21,000→ 21,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24$33.54/sh−2,909→ 56,988 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-06-24+6,000→ 59,897 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Performance share units
2025-06-24−6,000→ 6,000 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−1,681→ 53,897 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−1,187→ 49,911 total
Sale
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-03$35.54/sh−1,137→ 47,098 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Restricted stock units
2025-03-01−4,000→ 4,000 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+5,667→ 55,578 total
Exercise/Conversion
AGIOS PHARMACEUTICALS, INC.$AGIO
Common stock
2025-03-01+4,000→ 51,098 total

Companies

Recent Filings

Address

C/O VIRIDIAN THERAPEUTICS, INC. 221 CRESCENT STREET, SUITE 103A

WALTHAM, MA, 02453

View on SEC.gov